Abstract
Summary‘Drug-centred’ prescribing in psychiatry has been proposed as a new and better approach than the current ‘disease-centred’ alternative. It targets symptoms most important to the patient using the concept that psychotropics act indirectly by altering normal functioning. I contend that it is a straw man: psychiatrists already use ‘drug-centred’ prescribing, applying their knowledge of a drug's pharmacological profile and evidence base to treat each patient's symptoms, not their diagnostic classification. Furthermore, there is no compelling evidence that psychotropics act by altering ‘normal’ functioning: rather, they have diverse effects on different mental states.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference15 articles.
1. Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
2. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
3. Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
4. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis
5. Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxy-quetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors;Fisher;Therapeutic Drug Monitoring,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献